combines research expertise in pharmacology, biomedical engineering & drug delivery. We focus on the establishment of Next Generation Therapies, Nanomedicine, Tissue Engineering & Tissue Regeneration. We are particularly interested in healthy and diseased states of human epithelia with a current focus on inflammatory and genetic diseases of the human skin and lung. Our research is highly interdisciplinary and requires close collaborations with experts in the field of chemistry, medicine, and genetics.
Interview with Dr. Hedtrich on the delivery of genome editing tools: https://www.advancedsciencenews.com/delivering-crispr-gene-editing-therapy-whats-holding-us-back/
Interview with Dr. Hedtrich on advances in biomedical engineering and organ-on-a-chip devices published in the UBC TREK magazine: https://trekmagazine.alumni.ubc.ca/2021/spring-2021/health-science-technology/human-chip